Press

Here’s a statistic that might surprise you: women make up about half of the biotechnology workforce, but they hold only 30 percent of...

Most advice about what venture capitalists want comes from people who've only sat on one side of the table. Leen Kawas offers a different...

In the high-stakes world of biotechnology, where breakthrough discoveries can take decades and billions of dollars to develop, the...

Biotech’s diversity gap runs deeper than workforce stats. Although women make up around 50% of the industry, they occupy just 30% of...

Following a record-breaking $39 billion in venture capital funding in 2021, the U.S. biotech sector saw a sharp downturn. By 2023,...

Artificial intelligence is redefining every stage of the biotech pipeline—from discovery and development to clinical trials and...

A growing number of American parents recognize the importance of AI education, with 88% believing it will be vital to their children’s...

Leen Kawas, a leading biotech professional, highlights ways in which the return of US manufacturing can be beneficial to the economy, the industry, and the overall wellness of individuals.

In an increasingly complex healthcare landscape, biotechnology innovations are revolutionizing treatment approaches and improving patient outcomes. These advancements are reshaping scientific communities and healthcare systems through targeted therapies, precision medicine, and data-driven decision-making. Biotechnology leader Leen Kawas provides insights into how these innovations create a meaningful impact across the healthcare ecosystem.

Leen Kawas on Resilience as a Strategy: The Role of Female Leadership in Transformative Change

The integration of artificial intelligence and advanced technologies into healthcare and biotechnology presents both unprecedented...

Leen Kawas On The Power of Perspective: Women Transforming Leadership Through Vision and Vulnerability

Leen Kawas on navigating the next wave: women charting a course between innovation and inclusion.

The power of trust: Leen Kawas on cultivating trust in uncertain times

Leen Kawas discusses three financial issues biotech leaders should address in 2024.

Leen Kawas details the factors behind high drug development costs, and presents strategies to address them.

Leen Kawas details key strategies for increasing clinical trials' success rates.

Leen Kawas profiles biotechnology firms' partnerships with contract research organizations.

Dr. Leen Kawas discusses the power of workplace friendships: building stronger teams and enhancing job satisfaction.

Dr. Leen Kawas discusses the US biotechnology industry's changing dynamics and offers five strategic recommendations for 2025.